MANHATTAN RESEARCH: THREE WAYS FOR PHARMA PRODUCT SITES TO IMPROVE VISITOR SATISFACTION AND RETAIN CONSUMERS

Complimentary ePharma Consumer® v8.0 white paper from Manhattan Research explores how consumers find pharma information online and what features are most effective in meeting their needs

March 5, 2009, New York, NY – Pharmaceutical product sites are an important component of an overall brand strategy and can serve as a brand extender for consumers – providing an engaging brand experience that may not be fully realized in the time and space contraints of traditional media. Over 40 million U.S. adults turned to the Internet for additional information after DTC advertising last year, so it is critical that pharma companies have a solid online presence that meets the needs of interested consumers and empowers their treatment management.

To help pharmaceutical marketers understand how consumers find pharmaceutical information online and what features are most likely to satisfy and retain consumers, Manhattan Research’s offers a complimentary white paper, “Reaching Today’s ePharma Consumer.” The white paper is based on the rich market data and trends covered by the ePharma Consumer® study, which is focused on how consumers find and use pharmaceutical information online.  

This white paper gives an overview of the demographics and characteristics of those is online for pharmaceutical information and shares how these ePharma Consumers are finding pharmaceutical information online and the features and tools most important to them. It also reviews the pharma product sites that consumers rate highly for satisfaction and explains why these sites are effective in meeting visitor needs.

The paper discusses a few features and factors that are important to consumers and are worthwhile for pharmaceutical marketers to consider when planning online strategy:

Customer Service - More than three-quarters of ePharma Consumers report that they “expect” online customer service from a pharmaceutical company. Giving site visitors easy access to customer service representatives and providing information on how to manage prescription costs are good ways to enhance relationships with customers and give them a more personal interaction with the company.

Prescription Cost - Product affordability is an important health issue for consumers – product price comparison sites are one of most popular online tools for consumers online for health information, and over four-fifths of ePharma Consumers are interested in obtaining pricing information for pharmaceutical products they take. Coming off of a year during which about 40 million U.S. adults decided not to fill a prescription medication from a doctor because of the cost, links to free trials, coupons, and formulary information can help meet the needs of today’s consumers.

Format Choice - Consumers vary in their preferences for receiving information – some are more engaged by rich media and interactive features and tools while others are just looking for text-based product information. To help meet the needs of a greater number of consumers, consider supplementing product directions with an instructional online video and integrating product commercials on the site. The more options visitors have for digesting information, the more people a site is likely to satisfy.

Download the Full White Paper
To access the full “Reaching Today’s ePharma Consumers” white paper, please visit: http://www.manhattanresearch.com/research/white-papers/reaching-epharma-consumers.aspx

  About ePharma Consumer® v8.0  
ePharma Consumer® v8.0 is Manhattan Research’s consumer market research and strategic advisory service focused on consumers online for pharmaceutical information. In addition to the use of search engines for health and pharma information, ePharma Consumer® covers the impact of social networking/Web 2.0 and tracks consumer interaction with more than 250 branded and unbranded pharmaceutical sites, including in-depth data on the effect of DTC advertising, visitation, site search rationales, desired site tools and features, and actions taken off-site.

ePharma Consumer® v8.0 was conducted via online survey in Q4 2008 among 6,566 adults (age 18+). Overall market research can be segmented for over 85 condition groups. For additional product and subscription information, please visit http://www.manhattanresearch.com/products/Strategic_Advisory/ePC/

Some of the product sites covered in ePharma Consumer® include Abilify, Accurus, Aciphex, ACRYSOF® IOLs, Actemra, Actiq, Activase, Actonel, Actos, Actrapid, Adalat, Adderall (Xr), Adenocard, Adenoscan, Advair/Advair Diskus, Aldara, Alimta, Allegra, Altabax, Altace, Ambien/Ambien CR, Amevive, Amitiza, Androderm, Androgel, Angeliq, Apidra, Aranesp, Arava, Aricept, Arimidex, Asacol, Ascensia, Asmanex, Astelin, Atacand, Avandia, Avapro/Avalide, Avastin, Avelox, Avinza, Avodart, Avonex, Axert, Azor, Basen, Benicar, Benzaclin, Betaseron, Boniva, Botox, Cosmetic, Brovana, Byetta, Bystolic, Caduet, Campath, Carac, Carbatrol, Casodex, Celebrex, Celexa, Cellcept, Cerezyme, Chantix, Cialis, Cimzia, Clarinex, Colazal, Combivir, Concerta, Copaxone, Coreg CR, Cosopt, Cozaar/Hyzaar, Crestor, Cubicin, Cymbalta, Cypher Stent, Daptacel, Daytrana, Depakote ER, Depo-Provera, Detrol LA, Diovan, Ditropan XL, Duragesic, Effexor XR, Elidel, Eligard, Elitek, Ellence, Eloxatin, Emend, Enablex, Enbrel, Enjuvia, Epogen, Epzicom, Erbitux, Evista, Evoxac, Exelon, Exforge, Exubera, Famvir, Femara, Femcon Fe, Ferrlecit, Flomax, Flonase, Flovent HFA, Flumist, Follistim, Forteo, Fosamax, Fuzeon, Gardasil, Gemzar, Geodon, Gleevec, Glucobay, Glumetza XR, Hepsera, Herceptin, Humalog, Humira, Hyalgan, Imitrex, Invega, Invirase, Iressa, Isentress, Ixempra, Januvia, Juvederm, Kaletra, Kepivance, Keppra, Ketek, Kineret, Kogenate FS, Kuvan, Kytril, Lamictal, Lamisil, Lantus, Lescol Xl, Leukine, Levaquin, Levemir, Levitra, Lexapro, Lexiva, Lialda, Lidoderm, Lipitor, Livial, Loestrin 24 Fe, Lovaza, Lovenox, Lucentis, Lunesta, Lupron Depot, Lybrel, Lyrica, Mabthera, Macugen, Micardis, Mirapex, Mirena, Namenda, Nasacort AQ, Nasonex, Natrecor, Neulasta, Neupogen, Neupro, Neurontin, Nexavar, Nexium (Purplepill.com), Niaspan, Norditropin, Norvasc, Novolog Mix 70/30, Novoseven, NuvaRing, Omnaris, Optivar, Orencia, Ortho Evra, Ortho Tri-cyclen Lo, Oxytrol, Pataday, Paxil CR, Pegasys, Penlac, Pentasa, Plavix, Pravachol, Premarin, Prempro, Prevacid, Pristiq, Procrit, Prometrium, Propecia, Protonix, Provigil, Pulmicort, Ranexa, Raptiva, Razadyne, Rebif, Reclast, Relpax, Remicade, Requip, Restasis, Restylane, Reyataz, Rhinocort Aqua, Rilutek, Risperdal, Rituxan, Rozerem, Sculptra, Seasonale, Seasonique, Seroquel, Singulair, Skelaxin, Soma250, Spiriva, Sprycel, Strattera, Sutent, Symbicort, Symbyax, Symlin, Tamiflu, Tarceva, Taxotere, Tekturna, Teveten, Topamax, Toprol XL, Toviaz, Travatan Z, Trelstar, Treximet, TriCor, Truvada, Tykerb, Tysabri, Ultram ER, Uroxatral, Valtrex, Vectibix, Veramyst, Vesicare, Viagra, Vigamox, Viread, Visudyne, Viviant, Vytorin, Vyvanse, Welchol, Wellbutrin XL, Xalatan, Xeloda, Xenical, Xolair, Xopenex, Xyzal, Yasmin, Yaz, Zemplar, Zetia, Zithromax, Zocor, Zofran, Zolinza, Zoloft, Zometa, Zomig, Zostavax, Zyprexa, and Zyrtec.

About Manhattan Research
Manhattan Research, a Decision Resources Group company, conducts annual research studies covering eHealth trends among healthcare professionals and consumers in the Americas, Europe, and Asia. Broad research can be segmented by target specialist and therapeutic audiences. For more information please contact sales@manhattanresearch.com, call 1.888.680.0800, ext 2, or visit www.manhattanresearch.com.


About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

###

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:
 
Stephanie Cooper
Manhattan Research
212-255-1368
scooper@manhattanresearch.com
 
 
 


Health & Pharma Insight eNewsletter

Sign up to receive the latest research updates and eHealth trends.



Contact Us

For media inquiries or to speak with an analyst, please contact:

Stephanie Cooper
Manhattan Research
212-255-1368



Decision Resources Group brands include: